News DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-09-18 EDT			5-day change	1st Jan Change
89.35 ^USD	+1.61%		+7.61%	+34.62%

09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
09-16	Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing	MT

All News

Mentions Relevance

09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
09-16	Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing	MT
09-14	DexCom Promotes CFO Jereme Sylvain to Additional COO Role	MT
09-14	Dexcom, Inc. Announces Appointment of Jereme Sylvain as Executive Vice President and Chief Operating Officer, Effective September 14, 2026	CI
09-14	Dexcom Promotes Jereme Sylvain to Chief Operating Officer	BU
09-14	Dexcom Insider Sold Shares Worth $302,936, According to a Recent SEC Filing	MT
09-10	DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026	CI
09-10	Dexcom Appoints Glenn Boehnlein to Board of Directors	BU
09-09	DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM
09-01	Dexcom Announces Upcoming Conference Presentation	BU
08-24	Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT